Search results
The life sciences industry comprises companies operating in the research, development, and manufacturing of pharmaceuticals and many other products that improve the lives of organisms.
May 31, 2024 · In our 2024 Global Life Sciences Sector Outlook report, we emphasize on these key trends such as increasing pricing pressures, geopolitical environment, changes in US regulations, and the acceleration of Generative AI (GenAI) adoption to expedite drug discovery, cost reduction and revenue uplift.
Jan 9, 2024 · Read our latest research, articles, and reports on Life Sciences on the changes that matter most for the challenges and opportunities ahead.
Jan 31, 2023 · In this article, we explore some of the most recent trends in life sciences analytics and digital technology, and look ahead to what we might see next.
Apr 25, 2024 · The life science industry addresses critical global health and environmental challenges through rapid technological advancements and innovation, particularly in biotechnology, pharmaceuticals, and medical devices.
Dec 6, 2023 · Most life sciences executives surveyed have a cautiously positive outlook for their organizations in 2024. Many of them had some concerns about geopolitical tension and how they could impact global economies, markets, customers, and supply chains next year.
Sep 14, 2022 · Exciting progress in the life sciences industry is enabling companies to better predict, prevent, treat, and cure a wide range of diseases.
Jul 10, 2024 · In the latest Life Sciences industry outlook, RSM examines the current biopharma landscape, highlighting significant challenges and opportunities. One thing is certain: Funding remains a critical issue within the sector.
Apr 30, 2021 · 2021 global life sciences outlook. Possibility is now reality, sustaining forward momentum. Vicky Levy. United States. Navigating the pandemic has been an all-encompassing, once-in-a-lifetime challenge. Globally, life sciences companies responded with leadership and are emerging stronger.
Gene therapies, intelligent drug discovery and development, consumer wearables, telemedicine, and more—what are some of the drivers transforming the life sciences sector? How can biopharma and medtech organizations create new value in 2020, while tackling various challenges?
The 2023 KPMG US technology survey demonstrates how laser-focused digital acceleration and investments are enabling US businesses to capitalize on technology’s promise, even as they navigate economic, geopolitical, regulatory, and customer volatility. Learn more.
Jun 10, 2024 · According to reports, the nation’s life sciences sector alone generates over $112 billion in revenue. In light of biotech’s mounting economic impact, it’s no surprise that tech hubs across the country are witnessing a surge in life sciences companies, bolstering the nation’s status as a biotech epicenter.
Jan 23, 2024 · Baker Tilly’s outlook on what lies ahead for industry leaders. As we progress into 2024, it’s evident that the life sciences industry has proven to be highly resilient. This past year has been stable for life sciences whereas other industries have struggled with rapidly evolving economic challenges. Despite the ongoing success of the life ...
Jun 3, 2024 · Unleash holistic innovation for improved health outcomes and shareholder value. The life sciences industry faces increasing pressure to offer healthy returns to its investors by innovating new therapies.
The life sciences industry enters 2024 with measured optimism, signaling that the sector has reverted to its long-term trend for growth. A flurry of recent announcements, from strong initial public offerings to exciting new mergers and acquisitions, has breathed new life into the industry.
Dec 7, 2022 · The life sciences industry is a hypernym for businesses, organizations, and research institutions dedicated to protecting and improving organism life.
Our 2023 Global Life Sciences Outlook explores seven trends that are expected to shape the sector. In the coming year, the focus will remain on embracing digital technologies, navigating a changing regulatory landscapes and market volatility, and addressing health inequities.
Oct 28, 2020 · COVID-19 has accelerated new ways of working in the life sciences industry that have been talked about for years—chief among them a shift to patient and customer centricity, digital interactions, and workforce agility. Almost overnight, R&D teams reprioritized new research, plant and network experts rallied to ensure clinical supply ...
Mar 2, 2021 · A report released by the Urban Land Institute (ULI) Understanding the Life Sciences Sector: The Case for Investment provides an overview and insights about trends, drivers, and leading approaches on the life sciences sector in the real estate industry in Europe.
The life sciences industry encompasses various fields, including biotechnology, pharmaceuticals, medical devices, and diagnostics. This industry is critical in improving human health and quality of life by developing new treatments, drugs, and medical devices.
Jul 11, 2024 · Last year, biotech companies raised a total $30.6 billion over 12 months, meaning the life sciences industry is on track to exceed that figure in 2024.
Apr 18, 2023 · About 80% of surveyed medtech executives said the development of innovative products would be a top priority in 2023, according to our U.S. life sciences industry outlook; and 75% intend to focus more on their research and development (R&D) investments.
Jul 10, 2024 · The life sciences industry is heavily regulated, which has a direct impact on content creation and delivery. From FDA guidelines to international standards, content authors must be well-versed in these regulations to ensure compliance. This involves regular updates to training materials and educational content to reflect the latest regulatory ...
1 day ago · Harvard Business School (HBS) has named its 2024-25 Blavatnik Fellows and the program’s eleventh cohort. Launched in 2013, the Blavatnik Fellowship in Life Science Entrepreneurship is part of a gift from the Blavatnik Family Foundation to Harvard University. The Blavatnik Fellowship offers HBS alumni and Harvard-affiliated postdoctoral researchers the opportunity to advance new ventures ...
Jul 11, 2024 · Equity finance raised by the UK life sciences industry fell to £2.9 billion in 2023, down from £3.4 billion in 2022, a decrease of 14%. This marks the second year-on-year decline since 2021.
Dec 14, 2022 · McKinsey has identified four ways that companies can maintain resilience through a crisis: taking bold action on direct and indirect costs, continuing to fund innovation, adopting a through-cycle approach to M&A, and creating operational and financial optionality early in the crisis.
19 hours ago · Pune-headquartered IT company Zensar Technologies announced the acquisition of pharma and life sciences consulting firm BridgeView Lifesciences for a total deal value of $25 million. This will allow the firm to expand its healthcare offerings. Click here to connect with us on WhatsApp “The company ...
Jan 30, 2020 · From our work in life sciences and other industries, we have highlighted the ten technology plays required to become a leading technology organization across three vectors: Reimagine the role of technology, with a shared, business-backed vision focused on user-centric products.
Jul 9, 2024 · Canada’s Biomanufacturing and Life Sciences Strategy presents a long-term vision to protect Canadians against future pandemics and other health emergencies and to grow an innovative, competitive domestic life sciences sector.. STEMCELL Technologies was founded in 1993 by CEO Dr. Allen Eaves. The company has since grown into a global biotechnology enterprise, producing high-quality cell ...
Aug 3, 2022 · The life science industry has a value proposition that can help it build tech talent at scale, but realizing its potential will require new approaches. Organizations that are serious about strengthening their tech talent foundations should make tech talent a top five agenda item for their executive teams and boards. This could create an urgent ...
Realizing the potential of cloud-enhanced tech solutions. Among emerging technology in health care, there’s palpable enthusiasm behind AI. This enthusiasm is driven, in part, by the democratization of AI algorithms, toolkits, and the availability of high-performance computing (HPC) in the cloud.
